Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early-onset
disease requiring preterm delivery is associated with a higher risk of complications in both …

For the past decades, growing attention has been given to aspirin use during pregnancy. It
favors placentation by its proangiogenic, antithrombotic, and anti‐inflammatory effects …

Background Patients with chronic hypertension are at increased risk for superimposed
preeclampsia. The 2016 American College of Obstetricians and Gynecologists guideline …

Background Primary headaches (migraine, tension headache, cluster headache, and other
trigeminal autonomic cephalgias) are common in pregnancy and postpartum. It is unclear …

Studies reported that women in a low‐risk cohort with stage 1 hypertension defined as 130–
139 mmHg/80–89 mmHg, according to the American College of Cardiology/American Heart …

Objective This study aimed to:(1) identify all relevant studies reporting on the diagnostic
accuracy of maternal circulating placental growth factor) alone or as a ratio with soluble fms …

Objective Preeclampsia is a common disease during pregnancy that leads to fetal and
maternal adverse events. Few head-to-head clinical trials are currently comparing the …

Objectives To evaluate, in a Chinese population, the performance of a screening strategy for
preterm pre‐eclampsia (PE) using The Fetal Medicine Foundation (FMF)'s competing‐risks …

Background The Fetal Medicine Foundation proposed a competing risks model for early
identification of women at a high risk of preterm preeclampsia, typically associated with deep …

Preeclampsia (PE) is a pregnancy-specific disease, occurring in~ 2–10% of all pregnancies.
PE is associated with increased maternal and perinatal morbidity and mortality …